Publications and reports
Below is a list of publications that use data held by the Cancer Institute NSW.
This includes:
- NSW Cancer Registry
- NSW Clinical Cancer Registry (2008–2012)
- BreastScreen NSW
- NSW Pap Test Register
- Cancer Institute Tobacco Tracking Survey
Published date 07 March 2016
Aboriginal people with colorectal cancer had poorer survival rates than non-Aboriginal people in NSW, although rates of surgical treatment, complications and follow-up colonoscopy were similar.
Published date 03 March 2016
Increasing Disadvantages in Cancer Survival in New Zealand Compared to Australia, between 2000-05 an
Greater improvements in cancer survival between 2000 and 2010 were seen in Australia than in New Zealand. Efforts to improve early diagnosis and treatment may help New Zealand catch up with the progress in Australia.
Published date 01 March 2016
Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-200
Australia's malignant mesothelioma incidence rates appear to have reached maximum levels but with differences over time by age, gender and tumour location.
Published date 01 March 2016
The Australian National Bowel Cancer Screening Program invitees had less risk of dying from colorectal cancer, and were more likely to have less-advanced colorectal cancers when diagnosed, than noninvitees.
Published date 01 February 2016
Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Wome
The inclusion of genetic information improved breast cancer clinical risk prediction models by more than 20%.
Published date 01 February 2016
Cancer survival in New South Wales, Australia: socioeconomic disparities remain despite overall impr
Source:
BMC Cancer. 2016 Feb 1;16(1):48
Differences in cancer survival by socioeconomic status have not reduced despite increases in overall cancer survival in NSW. About 13.4% of cancer deaths could have been postponed if this socioeconomic disparity was eliminated.
Published date 01 February 2016
Lower socio-economic status was a predictor of distant stage at cancer diagnosis in NSW.
Published date 28 January 2016
Breast cancer recurrence following active treatment: determining its incidence in the NSW population
A cohort of women in NSW had an annual recurrence rate of 3.3% for the period 18 months to 6 years after diagnosis of primary breast cancer. The study identifies factors associated with a higher incidence of recurrence.
Published date 01 January 2016
Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer - a populat
Source:
Acta Oncol. 2016;55(2):226-33.
Receipt of standard adjuvant chemotherapy at a relative dose intensity of 70% or less was associated with poorer survival in women with epithelial ovarian cancer.
Published date 01 January 2016
Linked cancer registry and hospital data can increase system-wide understanding of local health-service delivery for lung cancer.
